Phosphate Binders in CKD: ‟New Kids on the Block”
DOI :
https://doi.org/10.53778/pjkd31089Mots-clés :
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideRésumé
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Téléchargements
Publié
2021-02-05
Numéro
Rubrique
Review Article
Licence
© Muhammad Umair Afzal, Shafeeq Cheema 2021
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale 4.0 International.
Comment citer
Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089
